Back

Long-term survival outcomes and baseline hemodynamics in patients with PAH versus CTEPH

12 May 2024 (11:00 - 13:00)
Organised by: Logo
Congress Presentation Part of: ePosters in valvular and pulmonary 4 Pulmonary Hypertension HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Joana Mesquita Guimaraes

University Hospitals of Coimbra, Coimbra (Portugal)

3 More presentations in this session

Presentation thumbnail
Exploring the clinical relevance of TSAT <21% as an iron deficiency indicator in pulmonary arterial hypertension: a comparative analysis with alternative criteria and existing guidelines
Doctor N. Ilchyshyn (Almada, PT)
Abstract Slides Video
Presentation thumbnail
Real-world results of selexipag in treating pulmonary hypertension in a portuguese population
Doctor J. Mesquita Guimaraes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
HFWM: exploring biomarkers in chronic thromboembolic pulmonary hypertension (CTEPH): prognostic significance, and post-PEA dynamics analysis
Doctor A. Cuomo (Naples, IT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in valvular and pulmonary 4

The Event

Event poster

Heart Failure 2024

12 May 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Heart failure with preserved ejection fraction and pulmonary hypertension: a survival analysis in a hispanic population
thumbnail
Congress Presentation
Clinical, echocardiographic and haemodynamic predictors of morbidity and mortality in pulmonary hypertension: a nation-wide registry
thumbnail
Congress Presentation
Prognostic value of follow-up hemodynamics after initial treatment in pulmonary arterial hypertension

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources